INtravenous TNK for Acute isChemicsTroke in China

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

April 9, 2024

Study Completion Date

April 9, 2024

Conditions

Stroke, Ischemic

Interventions

DRUG

rhTNK-tPA

Thrombolysis

Trial Locations (1)

Department of Neurology, General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors

lead

General Hospital of Shenyang Military Region

OTHER

NCT04588337 - INtravenous TNK for Acute isChemicsTroke in China | Biotech Hunter | Biotech Hunter